-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23

Benzinga·09/18/2026 12:46:20
Listen to the news
B. Riley Securities analyst Madison El-Saadi assumes Anika Therapeutics (NASDAQ:ANIK) with a Buy rating and raises Price Target to $23.